The FDA has recently issued a letter to the makers of Harmonyx, a pharmacogenetic test that can be used to help determine the best medication to use for ADHD. This letter cites concerns that the test is being marketed without appropriate FDA clearance.
The company has voluntarily pulled the test from the market as it cooperates with the FDA in its' investigation of the matter. However, the company denies that the test is being marketed directly.to consumers, and states that it believes that it is in compliance with the FDA's regulations.
11/10/2016
Harmonyx issued a letter to consumers stating that they will not be offering testing anymore because of the overwhelming costs associated with pursuing FDA approval for direct to consumer marketing.
Excellent information on your blog,thank you for taking the time to share with us.I’m really amazed with your posting skills as well as with the layout on your blog site.Very informative and well written post! Quite interesting and nice topic chosen for the post Nice Post keep it up.Excellent post.
ReplyDeletepharmacogenetic testing cost
This comment has been removed by the author.
ReplyDelete